Similar articles

• Re: factors associated with the adoption of minimally invasive radical prostatectomy in the United States: w. D. Ulmer, s. M. Prasad, k. J. Kowalczyk, x. Gu, C. Dodgion, s. Lipsitz, g. S. Palapattu, T. K. Choueiri and j. C. Hu j urol 2012; 188: 775-780.

  Witt JH, Zugor V, Labanaris AP. Witt JH, et al. J Urol. 2013 Mar;189(3):1169-70. doi: 10.1016/j.juro.2012.09.169. Epub 2012 Oct 11. J Urol. 2013. PMID: 23063803 No abstract available.
• Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.

  Yu X, Elliott SP, Wilt TJ, McBean AM. Yu X, et al. J Urol. 2008 Jul;180(1):241-5; discussion 245. doi: 10.1016/j.juro.2008.03.039. Epub 2008 May 21. J Urol. 2008. PMID: 18499180
• Editorial comment re: Trends and attitudes in surgical management of benign prostatic hyperplasia - pages 6170-6175.

  Hueber PA, Zorn KC. Hueber PA, et al. Can J Urol. 2012 Apr;19(2):6176-7. Can J Urol. 2012. PMID: 22512960 No abstract available.
• Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.

  Djavan B, Eckersberger E, Handl MJ, Brandner R, Sadri H, Lepor H. Djavan B, et al. Can J Urol. 2010 Aug;17(4):5249-54. Can J Urol. 2010. PMID: 20735902 Review.
• Benign prostatic hyperplasia.

  Brazilian Society of Urology, Brazilian Medical Association; Nunes RLV, Antunes AA, Silvinato A, Bernardo WM. Brazilian Society of Urology, Brazilian Medical Association, et al. Rev Assoc Med Bras (1992). 2018 Oct;64(10):876-881. doi: 10.1590/1806-9282.64.10.876. Rev Assoc Med Bras (1992). 2018. PMID: 30517232 Review.